Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Benefit and risk of lower follow-up blood pressure after intracerebral haemorrhage Proceeding/Conference:Hong Kong Medical Journal	Teo, KCLeung, CYWYeung, CWong, YKChan, KHCheung, RTFHo, SLLau, GKK	2021
	Male SpA patients with longer disease duration have less severe disc degeneration— A propensity-score matched comparison with the population	Cheung, TYSCheung, JPYTsang, HLHCheung, WHP	2022
	Epidemiology, predictors of mortality and role of prophylaxis for pneumocystitis jiroveci pneumonia among rheumatic patients: a territory-wide study Proceeding/Conference:Annals of the Rheumatic Diseases	Chan, CWSChung, HYYeung, WYLau, WCSLi, PH	2021
	LDL-cholesterol and risk of recurrent vascular events in Chinese ischaemic stroke patients with and without significant atherosclerosis Proceeding/Conference:7th European Stroke Organisation Conference	Lau, GKKChua, BJNg, ALeung, IYHWong, YKChan, HYAChiu, YKChu, AXWLeung, WCYTsang, COATeo, KCMak, HKF	2021
	A Feasibility Study of 0.055T MRI for Neuroimaging and Comparison with Clinical 3T MRI Proceeding/Conference:2022 Proceedings of Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting, Virtual Conference	Leong, TLLiu, YZhao, YXiao, LMak, HKFTsang, COALau, GKKLeung, GKKWu, EX	2022
	Perioperative anaphylaxis in Hong Kong: Our 10-year experience Proceeding/Conference:Hong Kong Institute of Allergy Annual Scientific Meeting 2022	Au, EYLMak, HWFLi, PHLau, WCSWong, JCYChiang, VYeung, HHFLam, KChan, K	2022
	Safety, pharmacokinetics (PK), and antiviral activity of the capsid assembly modulator (CAM) ALG-000184 in Asian and non-Asian subjects with chronic hepatitis B (CHB) Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMFAgarwal, KGane, EJucov, ASchwabe, CLe, KMassetto, BWestland, CZhang, QLBlatt, LLin, T-IChanda, SMcclure, MFry, J	2022
	EDP-514, a potent pangenotypic class ii hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B infected patients Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Yuen, RMFChuang, W-LPeng, C-YJeng, WJSu, W-WChang, TTChen, CYHsu, Y-CDe La Rosa, GAhmad, ALuo, EConery, AAdda, N	2021
	Factors associated with sleep apnoea prevalence in patients with stroke: a systematic review and meta-analysis Proceeding/Conference:Hong Kong Medical Journal	Liu, XDLam, CLDChan, HYAIp, MSMLau, GKK	2021
	Sleep quality is associated with cognitive performance in minor stroke Proceeding/Conference:7th European Stroke Organisation Conference	Liu, XDoubal, FChappell, FClancy, UArteaga, CJaime, GDHewins, WJochems, AHamilton, OWiseman, SSakka, EValdes-Hernandez, MCStringer, MThrippleton, MLau, GKKWardlaw, J	2021
	Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Gane, ELocarnini, SLim, THStrasser, SISievert, WCheng, WThompson, AJGiven, BDSchluep, THamilton, JBiermer, MKalmeijer, RBeumont, MLenz, ORidder, FDCloherty, GWong, DKHSchwabe, CJackson, KFerrari, CLai, CLGish, RYuen, RMF	2022
	Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMFLim, Y-SCloutier, DThanawala, VShen, LArizpe, ATay, CGupta, SVCathcart, ALHwang, CGane, E	2022
	Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies Proceeding/Conference:Hong Kong Institute of Allergy Annual Scientific Meeting 2022	Chiang, VKan, AKCYim, SHJLee, EAu, EYLLi, PH	2022
	Rapid HBsAg reduction in chronic hepatitis B virus infection: preliminary results from a phase 1 study evaluating a single dose of VIR-3434, a novel neutralizing, vaccinal monoclonal antibody Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Agarwal, KYuen, RMFWedemeyer, HArizpe, AShen, LCloutier, DTay, CGupta, SVFanget, MCDholakiya, SLSeu, LCathcart, ALHwang, CPang, PSGane, EJ	2021
	Differential patterns of virological relapse and remission after discontinuation of tenofovir disoproxil fumarate or entecavir: results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection (RETRACT-B Study) Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Choi, HSJHirode, GChen, CHSu, T-HWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, R-NFeld, JJForns, XSonneveld, MJPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HLYKao, J-HHsu, Y-CCornberg, MHansen, BEJeng, WJJanssen, HLY	2021
	Early on-treatment hbv rna and HBcrAg profiles predict favourable HBsAg suppression or seroclearance upon long-term nucleos(t)ide analogue therapy in chronic hepatitis B infection Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Mak, LYWong, DKHKuchta, AHilfiker, MHamilton, ASeto, WKWYuen, RMF	2021
	Distinct bile acid profiles in chronic hepatitis b are influenced by HBV DNA levels and presence of concomitant steatosis Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	CHAU, HTZhang, SHuang, FYWong, DKHMak, LYFung, JYYYuen, RMFSeto, WKW	2021
	A simple screening tool for obstructive sleep apnoea can identify transient ischaemic attack or minor stroke patients with a high burden of cerebral small vessel disease Proceeding/Conference:7th European Stroke Organisation Conference	Liu, XLam, CLDLiu, KCRIp, MSMLau, GKK	2021
	Plasma bile acid profiles are associated with the presence of fibrosis in patients with concomitant nonalcoholic fatty liver diseases and chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	CHAU, HTZhang, SHuang, FYWong, DKHMak, LYFung, JYYYuen, RMFSeto, WKW	2022
	MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia Proceeding/Conference:Clinical Lymphoma Myeloma and Leukemia	Mesa, RKomatsu, NSingh, GHHJin, JLee, SEHou, HASato, TQin, AUrbanski, RShih, WOleh, ZCraig, CVerstovsek, S	2022